German Tech Holding Examines Investment in Cancer Diagnostics Biotech Startup

German Tech Holding GmbH & Co. KGaA is considering an investment in a biotechnology startup that has developed a disruptive radiopharmaceutical for cancer diagnostics, which has shown clinical proof.